IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE"). This ...

IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the ...

According to the CDC, up to 600,000 Americans are diagnosed with deep vein thrombosis (DVT) or pulmonary embolisms (PE) each year. These blood clots kill between 60,000 and 100,000 people annually, ...

Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. Commercial-stage medical device ...

Thrombolytics, intravenous or catheter-directed, can be an effective treatment option for acute pulmonary embolism (PE) but pose a hazard to the many patients who have risk factors for serious ...

The clot-removing device maker is nearly perfect, and it's priced like it. The system of veins, arteries, and capillaries in our bodies could stretch around the world more than two times. That's a ...

According to the CDC, up to 600,000 Americans are diagnosed with deep vein thrombosis (DVT) or pulmonary embolisms (PE) each year. These blood clots kill between 60,000 and 100,000 people annually, ...